Pediatric primary care has become an important venue for providing mental health services to children and adolescents. Integrated interventions with primary care providers as partners in the Medical Home Model designed to address mental health problems in pediatric health care can create optimal productivity and functionality for clinicians in joint patient care. This activity will discuss the role of effective integrated behavioral health care to aid in maximizing effectiveness and efficiency in joint visits.

Pediatric primary care providers play an important role in addressing behavioral health (BH) problems and the delivery of services to address these problems. This activity will discuss the management and treatment for pediatric aggression and the core symptoms of disruptive mood dysregulation disorder (DMDD), conduct disorder (CD), oppositional defiant disorder (ODD), and early onset bipolar disorder. ASD with aggressive behavior will also be highlighted.

This activity will discuss the association between hearing loss and cognitive burden, as well as the potential impact of untreated hearing loss. It will provide communication and management techniques for caregivers to accommodate changes in the cognitive status of those with hearing loss, as well as tools and strategies that are recommended by the Hearing Loss Association of America (HLAA) and how these can be put into practice.

Bladder cancer (BC) is the tenth most common cancer worldwide, and its associated five-year survival rate declines rapidly (from 96% to 6%) as it progresses from in situ through local invasion, regional spread and finally to distal spread. Thus, early detection and timely therapeutic interventions are crucial to improve outcomes and reduce the burden of disease. Outcomes have been further improved by the integration of recently approved therapies for BC, the utilization of biomarkers to guide treatment plans and the opportunity for eligible patients with BC to enroll in clinical trials. For all treatment plans, effective communication among the health care team is crucial for providing comprehensive care for this condition. This activity will provide participants with an overview of early BC diagnosis and its impact on survival rates. It will explore recently approved therapies for BC both as standalone treatments and in combination with established therapeutic approaches. Emerging therapies and their potential benefits will be examined, and the value of biomarkers will be discussed. Participants will gain insight into treatment strategies to optimize patient outcomes in BC.